Ophthalmic Clincial Trials support clinical research focused on dry eye disease and ocular surface disorders, providing access to patient populations and diagnostic assessments.
We work with sponsors, CROs and medical device manufacturers evaluating emerging treatments, technologies and therapeutic approaches for some of the most common and challenging ocular surface conditions.

Our team has comprehensive experience across a broad range of anterior eye and ocular surface indications, including:
Accurate and reproducible endpoint assessments are essential in dry eye and ocular surface clinical research.
Our team performs a comprehensive range of clinical evaluations, including:
These assessments support both efficacy and safety endpoints across pharmaceutical, device and combination product studies.

We support a wide range of dry eye and ocular surface research programs, including:
If you are planning a dry eye disease study, meibomian gland dysfunction trial, ocular surface research project or anterior eye clinical trial, we would welcome the opportunity to discuss your study requirements.
